drugset / Trial / NCT00913289

Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells

NCT00913289 ↗

Phase 1 Terminated 6 enrolled Kanazawa University
NaSingle-groupOpen-labelTreatment

Summary

Mesenchymal stem cells have the capability to differentiate into hepatocytes and will be useful for liver regeneration. Adipose tissue is relatively enriched with mesenchymal stem cells compared to bone marrow tissue. In this trial, eligible liver cirrhosis patients will receive autologous adipose tissue derived stromal cells which include such mesenchymal stem cells.

Timeline

Start
2009-02
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject adipose tissue derived stromal cells Cell therapy — —

Indications